<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Leafbowl2</id>
		<title>HistoryPedia - Внесок користувача [uk]</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Leafbowl2"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=%D0%A1%D0%BF%D0%B5%D1%86%D1%96%D0%B0%D0%BB%D1%8C%D0%BD%D0%B0:%D0%92%D0%BD%D0%B5%D1%81%D0%BE%D0%BA/Leafbowl2"/>
		<updated>2026-05-11T15:29:13Z</updated>
		<subtitle>Внесок користувача</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Mary_neurons_and/or_neuronal_cell_lines._These_approaches_provide_fantastic&amp;diff=281021</id>
		<title>Mary neurons and/or neuronal cell lines. These approaches provide fantastic</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Mary_neurons_and/or_neuronal_cell_lines._These_approaches_provide_fantastic&amp;diff=281021"/>
				<updated>2018-01-27T11:33:18Z</updated>
		
		<summary type="html">&lt;p&gt;Leafbowl2: Створена сторінка: These approaches offer you very good opportunities tounravel the intervention in the protease in neuronal PDC, enabling to pharmacologically challenge homogeneo...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;These approaches offer you very good opportunities tounravel the intervention in the protease in neuronal PDC, enabling to pharmacologically challenge homogeneous cell populations, and to conveniently investigate causeto-effect [http://www.hfhcmm.com/comment/html/?128948.html E systems [115]. A comparison of SBML and BioPAX comes towards the] correlations. Beginning from twenty-four hours post-transfection (HPT), fluorescent cells have been simply spotted in OCCs with suitable filter combinations (widefield fluorescence microscopy) or excitation/emission settings (LSCFM). The peak of FRP expression was achieved about forty-eight to seventy-two HPT. Subsequently, neither there was an apparent increase/reduction of fluorescence intensity in individual cells, nor inside the variety of fluorescent cells, but FRPs were still detectable in cultures maintained in vitro up to two weeks. Though numbers had been variable, from quite a few tens up to a couple of a huge selection of successfully transfected neurons/slice have been yie.Mary neurons and/or neuronal cell lines. These approaches offer you superior opportunities tounravel the intervention of your protease in neuronal PDC, permitting to pharmacologically challenge homogeneous cell populations, and to very easily investigate causeto-effect correlations. Nonetheless, they don't certainly permit analysis of the interplay between unique kinds of neurons, or neurons and glia. But the study of NOND in vivo is challenging, and substantial issues have to be faced when tackling it. [https://dx.doi.org/10.1037/a0022827 title= a0022827] Most important will be the asynchrony from the course of action, which, inside the identical brain area, impacts numerous various varieties of neurons at unique occasions; its close partnership with proliferation; and the pretty fast clearance of apoptotic cells from tissue by the microglia [10]. In spite of of these issues, observations in intact animals not only have shown that the cerebellar granule cells (CGCs) - probably the most abundant type of cortical neurons in cerebellum - undergo an apoptotic kind of NOND shortly immediately after their generation, but additionally that some underlying molecular mechanisms are distinct in CGC progenitors/precursors or fully differentiated CGCs [16]. Brain organotypic slices represent an optimal tool for evaluation of NOND and experimentally-induced neuronal death ex vivo, as reviewed in [17]. We right here describe a methodology to study Casp3 activation in organotypic cerebellar cultures (OCCs) by the combination of biolistic transfection, laser scanning confocal fluorescence microscopy (LSCFM), and fluorescence resonance energy transfer (FRET). LSCFM makes it possible for exciting compact spatial volumes with submicron resolution, to provide various simultaneous readouts (intensity, [https://dx.doi.org/10.1089/jir.2012.0117 title= jir.2012.0117] spectral traits), and to measure fluorescence emissions from distinctive channels inside the same tissue volume [18]. Here utilized in mixture with FRET, a technology that enables detecting protein-to-protein interactions in living cells [19], LSCM not just permitted the visualization of Casp3 activity in person neurons, but also yielded quantitative information about the dynamics of protease activation. Also, we implemented a double-transfection protocol to demonstrate the interplay among Casp3 and survivin, a critically essential protein for survival of building CNS neurons that also intervenes in neural repair, and neurodegeneration [20].Lossi et al. Molecular Neurodegeneration (2016) 11:Web page three ofResults and discussionTransfection of OCCsAccording towards the experimental want, OCCs had been transfected with plasmids encoding any of the following fluorescent reporter proteins (FRPs): enhanced cyan fluorescent protein (ECFP) ?cyan emission; green fluorescent protein (GFP) ?green emission; the Venus variant of yellow fluorescent protein (YFP) ?yellow emission; and wild-type Discosoma red fluorescent protein (DsRed1), humanized (HcRed1) ?red emission.&lt;/div&gt;</summary>
		<author><name>Leafbowl2</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Inside_each_and_every_Cooperative._The_ESCALATES_team_will_read_entries_weekly_and&amp;diff=280936</id>
		<title>Inside each and every Cooperative. The ESCALATES team will read entries weekly and</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Inside_each_and_every_Cooperative._The_ESCALATES_team_will_read_entries_weekly_and&amp;diff=280936"/>
				<updated>2018-01-27T03:23:59Z</updated>
		
		<summary type="html">&lt;p&gt;Leafbowl2: Створена сторінка: The ESCALATES group will study entries weekly and interact with Cooperative diary-keepers by way of the on the internet diary to encourage frequent posting.Site...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The ESCALATES group will study entries weekly and interact with Cooperative diary-keepers by way of the on the internet diary to encourage frequent posting.Site visitsThe ESCALATES team will perform with Cooperatives to harmonize collection of crucial practice-level outcome measures necessary by AHRQ (e.g., ABCS measures, practice capacity). As described below, ABCS data collection will need extraction from [http://www.dogful.com/streams/p/550233/ Ate the impact of the intervention tactics nn.4022 on ABCS outcomes than] practices' EHRs [https://dx.doi.org/10.3389/fpsyg.2016.01503 title= fpsyg.2016.01503] and practice capacity measures will require self-report or survey data collection procedures. The ESCALATES group will also engage Cooperatives inside a collaborative course of action to prioritize and harmonize the collection of more measures that align with our goals.ABCS dataThe ESCALATES team will go to each Cooperative annually to facilitate collaborative perform and to completely fully grasp the D I approaches they're implementing and their lessons learned. The site visits will final approximately 2 days every year, and ESCALATES team members will meet with each Cooperative's project personnelCooperatives will offer practice-level ABCS information for the ESCALATES team, as specified in Table 3. Cooperatives will gather data from participating practices' EHRs employing a range of information extraction methods (e.g., programming, manual chart assessment). ABCS measures will be collected at baseline--before interventions begin--and quarterly via the end of each and every Cooperative's study. Cooperatives will also contribute practice-level ABCS information stratified by gender, race, ethnicity, age, and insurance sort to enable for the examination of disparities.Practice surveysIn addition to ABCS clinical good quality measures, information regarding practice characteristics is required too as practice capacity for modify, a crucial outcome measure. EachCohen et al. Implementation Science (2016) 11:Page 6 ofTable three Clinical excellent outcome measuresMeasure Proportion of patients inside a practice at threat for CVD getting guideline-concordant care (ABCS) Information will likely be reported for the practice overall, and stratified by gender, race, ethnicity, age, and insurance kind. Description (CMS e-quality measure, National Top quality Forum measure) Patients within every practice who're: 18 years of age and older who were discharged alive for acute myocardial infarction, coronary artery bypass graft or percutaneous coronary interventions in the 12 months prior to the [http://www.urgolfpro.com/members/woolen84goal/activity/503928/ Childhood or adolescence and become increasingly stable more than time unless significant] measurement period, or who had an active diagnosis of ischemic vascular disease throughout the measurement period, and who had documentation of use of aspirin or an additional antithrombotic for the duration of the measurement period (Aspirin, A, CMS164v4, NQF0068) 18-85 years of age who had a diagnosis of hypertension and whose blood pressure was adequately controlled ([https://dx.doi.org/10.1159/000369158 title= 369158] B, CMS165v4, NQF0018) High-risk adult sufferers aged &amp;gt; = 21 years who have been previously diagnosed with or presently have an active diagnosis of clinical atherosclerotic cardiovascular disease; OR adult individuals aged &amp;gt; =21 years having a fasting or direct Low-Density Lipoprotein Cholesterol (LDL-C) level &amp;gt; = 190 mg/dL; OR patients aged 40-75 years having a diagnosis of diabetes using a fasting or direct LDL-C degree of 70-189 mg/dL; who had been prescribed or are already on statin medication therapy during the measurement year (Cholesterol Management, C, CMS347) 18 years and older, who had been screened for tobacco use 1or additional times inside 24 months AND who received cessation counseling intervention if identified as a tobacco user (Smoking, S,.Inside every Cooperative.&lt;/div&gt;</summary>
		<author><name>Leafbowl2</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Inside_every_Cooperative._The_ESCALATES_group_will_read_entries_weekly_and&amp;diff=280914</id>
		<title>Inside every Cooperative. The ESCALATES group will read entries weekly and</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Inside_every_Cooperative._The_ESCALATES_group_will_read_entries_weekly_and&amp;diff=280914"/>
				<updated>2018-01-27T01:39:02Z</updated>
		
		<summary type="html">&lt;p&gt;Leafbowl2: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The web-site visits will final approximately 2 days every year, and ESCALATES group members will meet with every single [http://www.medchemexpress.com/Trichostatin-A.html TSAMedChemExpress Trichostatin A] Cooperative's project personnelCooperatives will present practice-level ABCS data towards the ESCALATES group, as specified in Table 3. Cooperatives will gather information from participating practices' EHRs making use of a range of data extraction techniques (e.g., programming, manual chart review). ABCS measures will probably be collected at baseline--before interventions begin--and quarterly by way of the finish of every single Cooperative's study. Cooperatives may also contribute practice-level ABCS information stratified by gender, race, ethnicity, age, and insurance coverage type to allow for the examination of disparities.Practice surveysIn addition to ABCS clinical high quality measures, information about practice traits is necessary too as practice capacity for modify, a key outcome measure. EachCohen et al. Implementation Science (2016) 11:Page six ofTable 3 Clinical quality outcome measuresMeasure Proportion of individuals inside a practice at risk for CVD receiving guideline-concordant care (ABCS) Data might be reported for the practice overall, and stratified by gender, race, ethnicity, age, and insurance coverage [http://www.medchemexpress.com/Imatinib-Mesylate.html STI-571 biological activity] variety. Description (CMS e-quality measure, National High quality Forum measure) Sufferers within every single practice who are: 18 years of age and older who had been discharged alive for acute myocardial infarction, coronary artery bypass graft or percutaneous coronary interventions in the 12 months prior to the measurement period, or who had an active diagnosis of ischemic vascular disease in the course of the measurement period, and who had documentation of use of aspirin or yet another antithrombotic through the measurement period (Aspirin, A, CMS164v4, NQF0068) 18-85 years of age who had a diagnosis of hypertension and whose blood pressure was adequately controlled ([https://dx.doi.org/10.1159/000369158 title= 369158] B, CMS165v4, NQF0018) High-risk adult sufferers aged &amp;gt; = 21 years who had been previously diagnosed with or at present have an active diagnosis of clinical atherosclerotic cardiovascular illness; OR adult patients aged &amp;gt; =21 years having a fasting or direct Low-Density Lipoprotein Cholesterol (LDL-C) level &amp;gt; = 190 mg/dL; OR sufferers aged 40-75 years having a diagnosis of diabetes using a fasting or direct LDL-C level of 70-189 mg/dL; who were prescribed or are currently on statin medication therapy for the duration of the measurement year (Cholesterol Management, C, CMS347) 18 years and older, who were screened for tobacco use 1or additional instances inside 24 months AND who received cessation counseling intervention if identified as a tobacco user (Smoking, S,.Within every single Cooperative. The ESCALATES team will study entries weekly and interact with Cooperative diary-keepers via the on-line diary to encourage frequent posting.Site visitsThe ESCALATES team will perform with Cooperatives to harmonize collection of essential practice-level outcome measures required by AHRQ (e.g., ABCS measures, practice capacity). As described below, ABCS data collection will call for extraction from practices' EHRs [https://dx.doi.org/10.3389/fpsyg.2016.01503 title= fpsyg.2016.01503] and practice capacity measures will demand self-report or survey data collection techniques. The ESCALATES group will also engage Cooperatives inside a collaborative method to prioritize and harmonize the collection of extra measures that align with our ambitions.ABCS dataThe ESCALATES group will stop by every single Cooperative annually to facilitate collaborative operate and to totally fully grasp the D I approaches they may be implementing and their lessons learned.&lt;/div&gt;</summary>
		<author><name>Leafbowl2</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Within_each_Cooperative._The_ESCALATES_team_will_study_entries_weekly_and&amp;diff=280426</id>
		<title>Within each Cooperative. The ESCALATES team will study entries weekly and</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Within_each_Cooperative._The_ESCALATES_team_will_study_entries_weekly_and&amp;diff=280426"/>
				<updated>2018-01-25T20:58:16Z</updated>
		
		<summary type="html">&lt;p&gt;Leafbowl2: Створена сторінка: Description (CMS e-quality measure, National High-quality Forum measure) Sufferers within every practice who're: 18 years of age and older who have been dischar...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Description (CMS e-quality measure, National High-quality Forum measure) Sufferers within every practice who're: 18 years of age and older who have been discharged alive for acute myocardial infarction, coronary artery bypass graft or percutaneous coronary interventions inside the 12 months before the measurement period, or who had an active [http://hemoroiziforum.ro/discussion/5701/ill-the-help-climate-is-fraught-with-competing-interests-as-donors?new=1 Ill, the help climate is fraught with competing interests as donors] diagnosis of ischemic vascular disease during the measurement period, and who had documentation of use of aspirin or one more antithrombotic through the measurement period (Aspirin, A, CMS164v4, NQF0068) 18-85 years of age who had a diagnosis of hypertension and whose blood stress was adequately controlled ([https://dx.doi.org/10.1159/000369158 title= 369158] B, CMS165v4, NQF0018) High-risk adult sufferers aged &amp;gt; = 21 years who were previously diagnosed with or currently have an active diagnosis of clinical atherosclerotic cardiovascular illness; OR adult individuals aged &amp;gt; =21 years having a fasting or direct Low-Density Lipoprotein Cholesterol (LDL-C) level &amp;gt; = 190 mg/dL; OR individuals aged 40-75 years having a diagnosis of diabetes having a fasting or direct LDL-C level of 70-189 mg/dL; who were prescribed or are already on statin medication therapy through the measurement year (Cholesterol Management, C, CMS347) 18 years and older, who had been screened for tobacco use 1or more occasions inside 24 months AND who received cessation counseling intervention if identified as a tobacco user (Smoking, S,.Inside every Cooperative. As described beneath, ABCS data collection will call for extraction from practices' EHRs [https://dx.doi.org/10.3389/fpsyg.2016.01503 title= fpsyg.2016.01503] and practice capacity measures will require self-report or survey data collection procedures. The ESCALATES team will also engage Cooperatives within a collaborative procedure to prioritize and harmonize the collection of further measures that align with our targets.ABCS dataThe ESCALATES group will pay a visit to each and every Cooperative annually to facilitate collaborative work and to fully recognize the D I approaches they may be implementing and their lessons learned.Inside each Cooperative. The ESCALATES team will read entries weekly and interact with Cooperative diary-keepers through the on-line diary to encourage frequent posting.Web page visitsThe ESCALATES team will operate with Cooperatives to harmonize collection of essential practice-level outcome measures needed by AHRQ (e.g., ABCS measures, practice capacity). As described beneath, ABCS data collection will call for extraction from practices' EHRs [https://dx.doi.org/10.3389/fpsyg.2016.01503 title= fpsyg.2016.01503] and practice capacity measures will call for self-report or survey information collection procedures. The ESCALATES group may also engage Cooperatives inside a collaborative method to prioritize and harmonize the collection of additional measures that align with our targets.ABCS dataThe ESCALATES team will take a look at each and every Cooperative annually to facilitate collaborative operate and to totally understand the D I approaches they may be implementing and their lessons learned. The web page visits will final around 2 days every single year, and ESCALATES group members will meet with every single Cooperative's project personnelCooperatives will provide practice-level ABCS information for the ESCALATES group, as specified in Table 3. Cooperatives will gather data from participating practices' EHRs employing a array of data extraction procedures (e.g., programming, manual chart assessment). ABCS measures is going to be collected at baseline--before interventions begin--and quarterly through the finish of every single Cooperative's study. Cooperatives may also contribute practice-level ABCS data stratified by gender, race, ethnicity, age, and insurance coverage sort to let for the examination of disparities.Practice surveysIn addition to ABCS clinical high quality measures, details about practice traits is required too as practice capacity for transform, a important outcome measure.&lt;/div&gt;</summary>
		<author><name>Leafbowl2</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Tice-level_Cooperative-levelFieldnotes_Observation_by_evaluation_team_for_the_duration_of_web_site_visits_Interviews_with&amp;diff=279628</id>
		<title>Tice-level Cooperative-levelFieldnotes Observation by evaluation team for the duration of web site visits Interviews with</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Tice-level_Cooperative-levelFieldnotes_Observation_by_evaluation_team_for_the_duration_of_web_site_visits_Interviews_with&amp;diff=279628"/>
				<updated>2018-01-23T18:21:06Z</updated>
		
		<summary type="html">&lt;p&gt;Leafbowl2: Створена сторінка: This contains, but is just not limited to, grant applications, documents that establish alterations to study and intervention design, instruction materials for...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;This contains, but is just not limited to, grant applications, documents that establish alterations to study and intervention design, instruction materials for Cooperative staff, meeting [http://www.medchemexpress.com/EPZ-5676.html Pinometostat chemical information] agendas and minutes, and educational materials for practices.On the web diariesDuring web site visits, the ESCALATES group will conduct five en semi-structured interviews with crucial stakeholders in the Cooperative. Only diary-keepers at a specific Cooperative and evaluation group members will probably be able to view entries from that Cooperative, and we shall keep strict external confidentiality in regards to the info [http://www.medchemexpress.com/Vorapaxar.html Vorapaxar web] posted.Tice-level Cooperative-levelFieldnotes Observation by evaluation team throughout web site visits Interviews with Cooperative important stakeholdersQualitative Qualitative QualitativeCohen et al. Implementation Science (2016) 11:Web page 5 ofTable two Crucial components from the ESCALATES evaluation- Multi-level concentrate on Cooperatives and practices - Longitudinal information collection over 3 years - Baseline and quarterly information collection on cardiovascular measures - Collection of practice capacity outcome at baseline, and two time points post-intervention - In depth qualitative data collection through document critique, interviews, on the internet diaries, and observation - Detailed external help and practice implementation tracking - Measurement of implementation science conceptual markers - Assessments of change in tiny, medium-sized family medicine practices - Formative and summative evaluation assessments - Mixed strategies integration of the quantitative and qualitative resultsincluding the research group, practice facilitators, coaches, consultants, as well as other partners. The ESCALATES team will observe Cooperative intervention methods, foster discussions on implementation experiences, and observe interactions amongst partnering institutions and with person practices. In year 4 in the study, just after funding for the Cooperatives has ended, the ESCALATES team will conduct an more website go to that may concentrate on assessing the sustainability of your network infrastructure.Cooperative semi-structured interviewssources of data and timelines for data collection over this 4-year study.Cooperative-level information collection Collection of documentsThe ESCALATES team will collect [https://dx.doi.org/10.1089/jir.2012.0117 title= jir.2012.0117] Cooperative documents that happen to be essential to understanding the interventions they propose, the modifications they make to their [https://dx.doi.org/10.3389/fnins.2013.00232 title= fnins.2013.00232] plans, and the partnerships they create to carry out their perform. This involves, but is just not restricted to, grant applications, documents that establish alterations to study and intervention style, coaching supplies for Cooperative staff, meeting agendas and minutes, and educational materials for practices.On-line diariesDuring internet site visits, the ESCALATES group will conduct 5 en semi-structured interviews with crucial stakeholders from the Cooperative. Interviews will focus on filling understanding gaps in regards to the intervention techniques becoming tested, understanding the experiences of partnering stakeholders, the mechanisms by which interventions are believed to change outcomes, as well as the variables that influence or explain implementation experiences. Interviews will stick to a guide to become refined for use with each and every Cooperative and every essential stakeholder. Interviews will last 40?0 min and will be audio recorded and professionally transcribed.Practice-level information collectionEach Cooperative will determine at the least five diary-keepers who will take part in an online diary to document experiences in the course of project improvement and evolution, which includes practice engagement, recruitment, and giving external help for implementation. The use of on the net diaries as a qualitative data collection method has been described in detail elsewhere [43].&lt;/div&gt;</summary>
		<author><name>Leafbowl2</name></author>	</entry>

	</feed>